https://www.selleckchem.com/pr....oducts/Imatinib-Mesy
The impact of genetic muscle disorders on quality of life in affected children are well-documented. However, few studies have investigated children's coping strategies and relationships between coping and quality of life. To determine coping strategy use, efficacy, and associations with quality of life in children with a genetic muscle disorder. Forty-eight children (6-15 years, 58%male) with a genetic muscle disorder were identified as part of a national prevalence study. Children completed the Kidcope in response to a specif
Like
Comment
Share
